Dexrazoxane Intravenous and Verapamil Extended Release Tablets
Determining the interaction of Dexrazoxane Intravenous and Verapamil Extended Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Verapamil Hydrochloride
- Dexrazoxane Intravenous-Verapamil Hydrochloride PM
- Dexrazoxane Intravenous-Verapamil Immediate-Release Tablets
- Dexrazoxane Intravenous-Verapamil Injection
- Dexrazoxane Intravenous-Verapamil Intravenous
- Dexrazoxane Intravenous-Verapamil Long-Acting Capsules
- Verapamil Extended Release Tablets-Dextenza Insert
- Verapamil Extended Release Tablets-Dextenza intraocular
- Verapamil Extended Release Tablets-Dextran 40
- Verapamil Extended Release Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Verapamil Extended Release Tablets-Dextran 75
- Verapamil Extended Release Tablets-Dextran high molecular weight